Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer.

S Danson; D Ferry; V Alakhov; J Margison; D Kerr; D Jowle; M Brampton; G Halbert; M Ranson

doi:10.1038/sj.bjc.6601856

Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer.

Identifier:nobleid.org/w1/20260515/9FC9DF3D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9FC9DF3D.svg?ark=w1%2F20260515%2F9FC9DF3D)](https://nobleid.org/work/w1/20260515/9FC9DF3D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer.

Identifier:nobleid.org/w1/20260515/9FC9DF3D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9FC9DF3D.svg?ark=w1%2F20260515%2F9FC9DF3D)](https://nobleid.org/work/w1/20260515/9FC9DF3D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work